查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
帶狀皰疹疫苗的中國市場(2022年～2031年)
市場調查報告書
商品編碼
1105810

帶狀皰疹疫苗的中國市場(2022年～2031年)

Investigation Report on China's Shingles Vaccine Market 2022-2031
出版日期: | 出版商: China Research and Intelligence | 英文 40 Pages | 商品交期: 最快1-2個工作天內

價格

2020年帶狀皰疹疫苗進入到中國市場以來，帶狀皰疹疫苗的年度銷售額達到1,900萬人民幣(285萬美元)，年度銷售數量達到約1萬2,000份。預計2022年～2031年之間市場擴大，銷售額持續增加。

本報告提供中國的帶狀皰疹疫苗市場相關調查分析，COVID-19的影響，市場規模，廠商分析，市場預測等資訊。

第1章 帶狀皰疹疫苗的相關概念

  • 帶狀皰疹疫苗的適應症
  • 中國的帶狀皰疹疫苗的開發
  • 中國的帶狀皰疹疫苗的政府核准
  • COVID-19對中國的帶狀皰疹疫苗的銷售的影響

第2章 中國的帶狀皰疹疫苗的銷售(2020年～2021年)

  • 帶狀皰疹疫苗的銷售額
    • 整體銷售額
    • 各地區的銷售額
  • 帶狀皰疹疫苗的銷售數量
    • 整體銷售數量
    • 各地區的銷售數量
  • 中國的帶狀皰疹疫苗的銷售:各投藥法(2020年～2021年)
    • 注射
    • 其他投藥法的分析

第3章 中國的主要帶狀皰疹疫苗製造商分析(2020年～2021年)

  • 主要的帶狀皰疹疫苗製造商市場佔有率分析
    • 市場佔有率調查:各銷售額
    • 市場佔有率調查:各銷售數量
  • GlaxoSmithKline Biologicals
    • 企業簡介
    • 中國的SHINGRIX(GlaxoSmithKline Biologicals公司的帶狀皰疹疫苗)的銷售

第4章 中國的各種製造商帶狀皰疹疫苗的價格(2021年～2022年)

  • GlaxoSmithKline Biologicals(SHINGRIX)
  • 其他

第5章 中國的帶狀皰疹疫苗市場預測(2022年～2026年)

  • 中國的帶狀皰疹疫苗市場開發的影響因素
    • COVID-19對中國的帶狀皰疹疫苗市場的影響
    • 推動市場要素和機會
    • 市場威脅與課題
  • 市場規模的預測
  • 市場趨勢的預測
Product Code: 2207580

The trade name of shingles vaccine (recombinant zoster vaccine) is SHINGRIX, which was developed by GlaxoSmithKline. Its product was firstly approved in China in 2020. Shingles vaccine is suitable for adults aged 50 years and over to protect against shingles (herpes zoster). The recombinant zoster vaccine has been listed in the Chinese market. By July 2022, GlaxoSmithKline Biologicals is the only manufacturer in the Chinese Shingles Vaccine market.

According to CRI's market research, since Shingles Vaccine entered the Chinese market in 2020, its annual sales value reached CNY19 million(US$2.85 million), and its annual sales volume reached nearly 12,000 doses. Therefore, the development prospects are quite good.

According to CRI analysis, from 2022 to 2031, as Shingles Vaccine market expands, its sales will continue to grow. Compared with Merck's Zostavax, SHINGRIX has better preventive effects and faster replacement velocity. Therefore, as the market share of Shingles Vaccine will gradually increase, and sales and sales volume will also increase.

Topics covered:

  • The impact of COVID-19 on China's Shingles Vaccine market
  • Sales volume and value of China's Shingles Vaccine 2020-2021
  • Sales volume and value of Shingles Vaccine by regions in China 2020-2021
  • Competitive landscape of China's Shingles Vaccine market
  • Prices of Shingles Vaccine in China
  • Prices of Shingles Vaccine in China by regions in China
  • Analysis on factors affecting the development of China's Shingles Vaccine market
  • Prospect of China's Shingles Vaccine market from 2022 to 2031

Table of Contents

1 Relevant Concepts of Shingles Vaccine

  • 1.1 Indications for Shingles Vaccine
  • 1.2 Development of Shingles Vaccine in China
  • 1.3 Governmental Approval of Shingles Vaccine in China
  • 1.4 The Impact of COVID-19 on Shingles Vaccine sales in China

2 Sales of Shingles Vaccine in China in 2020-2021

  • 2.1 Sales Value of Shingles Vaccine
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Regions
  • 2.2 Sales Volume of Shingles Vaccine
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Regions
  • 2.3 Sales of Shingles Vaccine by Dosage Form in China in 2020-2021
    • 2.3.1 Injection
    • 2.3.2 Analysis of Other Dosage Forms

3 Analysis of Major Shingles Vaccine Manufacturers in China in 2020-2021

  • 3.1 Analysis of Market Share of Major Shingles Vaccine Manufacturers
    • 3.1.1 Investigation on Market Share by Sales Value
    • 3.1.2 Investigation on Market Share by Sales volume
  • 3.2 GlaxoSmithKline Biologicals
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of SHINGRIX (GlaxoSmithKline Biologicals' Shingles Vaccine) in China

4 Prices of Shingles Vaccine for Different Manufacturers in China, 2021-2022

  • 4.1 GlaxoSmithKline Biologicals (SHINGRIX)
  • 4.2 Others

5 Prospect of Chinese Shingles Vaccine Market, 2022-2026

  • 5.1 Influential Factors of Chinese Shingles Vaccine Market Development
    • 5.1.1 The Impact of COVID-19 on Chinese Shingles Vaccine Market
    • 5.1.2 Market Drivers and Opportunities
    • 5.1.3 Market Threats and Challenges
  • 5.2 Forecast on Market Size
  • 5.3 Forecast on Market Trend

List of Charts

  • Chart Patent Information About Shingles Vaccine Injection Registration in China
  • Chart Sales Value of Shingles Vaccine Injection over the World
  • Chart Sales Value of Shingles Vaccine Injection in China in 2020-2021
  • Chart Sales Value of Shingles Vaccine Injection in China by Regions in 2020-2021
  • Chart Sales Volume of Shingles Vaccine Injection in China in 2020-2021
  • Chart Sales Volume of Shingles Vaccine Injection in China by Regions in 2020-2021
  • Chart Market Share by Sales Value of Top Shingles Vaccine Manufacturers in China in 2020-2021
  • Chart Sales Value and Volume of SHINGRIX in China in 2020-2021
  • Chart Referential Prices of SHINGRIX in China by Regions, 2021-2022
  • Chart Forecast on Sales Value of Shingles Vaccine in China, 2022-2031
  • Chart Forecast on Sales Volume of Shingles Vaccine in China, 2022-2031